Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 7/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.48 |
| ▸ | CYP2E1 | P05181 | 3/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.48 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.46 |
| ▸ | GRM5 | P41594 | 3/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | COMT | P21964 | 1/20 | 0.43 |
| ▸ | VHL | P40337 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.42 |
| ▸ | AXL | P30530 | 1/20 | 0.42 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.42 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.42 |
| ▸ | KMO | O15229 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6172906 | 0.92 | CYP2A6 (0.56) | CYP2A6CYP2C19CYP2E1CYP2C9CYP2B6 | |
| SCHEMBL5792405 | 0.90 | CYP2A6 (0.49) | CYP2A6CYP2C19CYP2E1CYP2C9CYP2B6 | |
| SCHEMBL5469881 | 0.79 | MIF (0.49) | CYP2A6CYP2C19CYP2E1CYP2C9CYP2B6 | |
| SCHEMBL6175240 | 0.79 | GRM5 (0.45) | GRM5KMOTSHRCYP19A1ALDH1A1 | |
| SCHEMBL19670662 | 0.78 | CYP2A6 (0.76) | CYP2A6CYP3A4GRM5MEN1PSIP1 | |
| SCHEMBL2732909 | 0.77 | CYP2A6 (0.50) | CYP2A6CYP2C19CYP2E1CYP2C9CYP2B6 | |
| SCHEMBL4197671 | 0.77 | GRM5 (0.64) | CYP2A6CYP3A4GRM5VHLMEN1 | |
| SCHEMBL24492855 | 0.76 | CYP2A6 (0.73) | CYP2A6CYP3A4GRM5MEN1PSIP1 | |
| SCHEMBL11965543 | 0.76 | CYP2A6 (0.73) | CYP2A6CYP3A4GRM5MEN1PSIP1 | |
| SCHEMBL5226124 | 0.76 | GRM5 (0.72) | CYP2C19CYP3A4GRM5CYP2D6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060217420-A1 | 4-Ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 | MERCK SHARP & DOHME CORP. | 2006-09-28 | — | — | US | claimed |
| CN-1768055-A | Fourth Ring imdazole derivatives as the metabotropic glutamate receptor-5 modulator | MERCK & CO INC (US) | 2006-05-03 | — | — | CN | claimed |
| EP-1613615-A2 | 4-RING IMIDAZOLE DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 | Merck & Co., Inc. (US) | 2006-01-11 | — | — | EP | claimed |
| WO-2004087653-A2 | 4-RING IMIDAZOLE DERIVATIVES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 | MERCK & CO., INC. (US) | 2004-10-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060217420-A1 | 4-Ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 | GRM5, GRIK5, GRM1 | CYP2A6 2302/4885CYP2C19 785/4885CYP2E1 619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.